Literature DB >> 3741356

Effects of POCA on metabolism and function in the ischemic rat heart.

D J Paulson, J J Noonan, K M Ward, H Stanley, A Sherratt, A L Shug.   

Abstract

Sodium 2-[5-(4-chlorophenyl)-pentyl]-oxirane-2-carboxylate (POCA) inhibits carnitine palmityltransferase I and fatty acid oxidation. The effects of POCA on cardiac function and on tissue levels of carnitine and coenzyme A esters were studied in the isolated rat heart subjected to 90 minutes of ischemia with and without 15 minutes of reperfusion. The perfusion medium contained 1.2 mM palmitate and 5.5 mM glucose plus or minus 0.5 mM POCA. This compound prevented accumulation of long-chain acylcarnitine and coenzyme A esters during ischemia and significantly improved the recovery of cardiac output after ischemia and reperfusion. Short-chain acylcarnitine levels were increased during ischemia by POCA. No effects were noted on tissue ATP and lactate levels. POCA may protect the ischemic heart by preventing accumulation of these toxic metabolites and by stimulating glucose utilization during ischemia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3741356     DOI: 10.1007/bf01907382

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  29 in total

1.  Microdetermination of (-)carnitine and carnitine acetyltransferase activity.

Authors:  R Parvin; S V Pande
Journal:  Anal Biochem       Date:  1977-05-01       Impact factor: 3.365

Review 2.  Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart.

Authors:  A J Liedtke
Journal:  Prog Cardiovasc Dis       Date:  1981 Mar-Apr       Impact factor: 8.194

3.  Changes in tissue levels of carnitine and other metabolites during myocardial ischemia and anoxia.

Authors:  A L Shug; J H Thomsen; J D Folts; N Bittar; M I Klein; J R Koke; P J Huth
Journal:  Arch Biochem Biophys       Date:  1978-04-15       Impact factor: 4.013

4.  Accumulation of nonesterified fatty acids in ischemic canine myocardium.

Authors:  F W Prinzen; G J Van der Vusse; T Arts; T H Roemen; W A Coumans; R S Reneman
Journal:  Am J Physiol       Date:  1984-08

5.  Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium.

Authors:  B E Sobel; P B Corr; A K Robison; R A Goldstein; F X Witkowski; M S Klein
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

6.  Effects of 2[5(4-chlorophenyl)pentyl]oxirane-2-carboxylate on fatty acid and glucose metabolism in perfused rat hearts determined using iodine-125 16-iodohexadecanoate.

Authors:  H S Sherratt; S J Gatley; T R DeGrado; C K Ng; J E Holden
Journal:  Biochem Biophys Res Commun       Date:  1983-12-28       Impact factor: 3.575

7.  Inhibition of carnitine palmitoyltransferase 1 by phenylalkyloxiranecarboxylic acid and its influence on lipolysis and glucose metabolism in isolated, perfused hearts of streptozotocin-diabetic rats.

Authors:  P Rösen; H Reinauer
Journal:  Metabolism       Date:  1984-02       Impact factor: 8.694

8.  Acyl-carnitine effects on isolated cardiac mitochondria and erythrocytes.

Authors:  M H Piper; O Sezer; P Schwartz; J F Hütter; C Schweickhardt; P G Spieckermann
Journal:  Basic Res Cardiol       Date:  1984 Mar-Apr       Impact factor: 17.165

9.  Inhibition of carnitine palmitoyl-CoA transferase activity and fatty acid oxidation by lactate and oxfenicine in cardiac muscle.

Authors:  D R Bielefeld; T C Vary; J R Neely
Journal:  J Mol Cell Cardiol       Date:  1985-06       Impact factor: 5.000

10.  Effects of reducing fatty acid metabolism on mechanical function in regionally ischemic hearts.

Authors:  A J Liedtke; S H Nellis; O D Mjøs
Journal:  Am J Physiol       Date:  1984-09
View more
  8 in total

Review 1.  Targeting myocardial substrate metabolism in heart failure: potential for new therapies.

Authors:  Hossein Ardehali; Hani N Sabbah; Michael A Burke; Satyam Sarma; Peter P Liu; John G F Cleland; Aldo Maggioni; Gregg C Fonarow; E Dale Abel; Umberto Campia; Mihai Gheorghiade
Journal:  Eur J Heart Fail       Date:  2012-02       Impact factor: 15.534

Review 2.  Complementarity of magnetic resonance spectroscopy, positron emission tomography and single photon emission tomography for the in vivo investigation of human cardiac metabolism and neurotransmission.

Authors:  A Syrota; P Jehenson
Journal:  Eur J Nucl Med       Date:  1991

3.  Elevated levels of nonesterified fatty acids in the myocardium of alloxan diabetic rats.

Authors:  J Chattopadhyay; E W Thompson; H H Schmid
Journal:  Lipids       Date:  1990-06       Impact factor: 1.880

4.  Role of catalase in myocardial protection against ischemia in heat shocked rats.

Authors:  S R Wall; H Fliss; B Korecky
Journal:  Mol Cell Biochem       Date:  1993-12-22       Impact factor: 3.396

5.  Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation.

Authors:  M M Awan; E D Saggerson
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

6.  Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation.

Authors:  P B Corr; M H Creer; K A Yamada; J E Saffitz; B E Sobel
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

7.  Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, Etomoxir.

Authors:  G D Lopaschuk; G F McNeil; J J McVeigh
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

Review 8.  Paradoxical role of lipid metabolism in heart function and dysfunction.

Authors:  N S Dhalla; V Elimban; H Rupp
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.